Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bios Life 2 (fiber/ nutrient supplement) - Nutraceuticals World
Research

Bios Life 2 (fiber/ nutrient supplement)

Indication: Cholesterol and homocysteine reduction

Source: J Metab September 2002;51(9):1166-70

Research: The study compared fasting blood samples from approximately 100 subjects over an eight-week period. All study participants followed the National Cholesterol Education Program (NCEP) Step 1 diet for six weeks prior to beginning the study. Additionally, no concurrent lipid-lowering therapy or statin during the previous 30 days was permissible. Those participants who still had LDL cholesterol greater than 130 mg/dl following the six week diet program were included in the study and were required to continue to follow the NCEP Step 1 diet for the duration of the investigation. Half of the study participants were given twice daily servings of Bios Life 2 and the other half were given a placebo. Neither the researchers nor the participants were aware of which substance any individual received.

Results: The group receiving Bios Life 2 had a significant reduction in LDL cholesterol levels averaging 8%, while LDL increased an average of 2% for the participants that received the placebo over the eight-week period, for a 10% difference between the groups. Similarly, total cholesterol levels for the Bios Life 2 group was significantly reduced by an average of 6%, while total cholesterol levels for the participants receiving the placebo rose an average of 3%. A significant reduction in blood homocysteine levels in the Bios Life 2 group was also observed. Homocysteine levels were found to drop significantly—an average of 11%—among the Bios Life 2 group, while those in the placebo group dropped an insignificant 2%.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters